EURETINA Educational Webinar: Mystery Uveitis: What would YOU do? (4 September 2024)
Sofia Androudi moderates an EURETINA Educational Webinar focusing on Uveitis alongside discussants Bahram Bodaghi & Carlos Pavesio, joined by a small group who have direct experience of the exam.
Format: Webinar
Access: Open Access
Episode 52: The Ophthalmologica Lecture: Dr Yousif Subhi
In this episode, Prof. Nicole Eter speaks with Dr. Yousif Subhi, this year’s Ophthalmologica lecturer about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research.
Episode 51: The Euretina Lecture: Professor Ohno-Matsui
In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein.
Episode 50: David Yorston on the Euretina/BEAVRS Database
Ahead of his prestigious Gisbert Richard lecture at this year’s upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database.
Episode 49: The Challenges and Opportunities for Young Retina Specialists
In this episode, Kristina Pfau (Switzerland) and Elon Van Dijk (The Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They’ll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers.
Episode 48: Assessing Visual Deficits in Intermediate AMD
In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar (UK), Principal Optometrist at Moorfields and UCL.
Episode 47: Gut bacteria and eye disease?
In this podcast, Bart Leroy (Belgium) and Mark Pennesi (USA) discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease).
Episode 46: How do you investigate your uveitis patient in 2024?
In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)
Episode 45: Robert J Johnston on Lab-Grown Retinas
In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins University (USA) who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research?
Chaired by Jonathan McCrea (Ireland).
Episode 44: Second Eye Risk: Navigating Prophylaxis in Retinal Detachment, GRT, and Sticklers
In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK).
Episode 43: Spoilt for choice – the many treatments now available for AMD and DME
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes.
